Marvel Biosciences Corp.
MRVL.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 93.10K | 281.50K | 41.10K | 59.80K | 250.30K |
| Total Receivables | 121.10K | 65.10K | 92.00K | 89.60K | 83.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.90K | 15.60K | 18.30K | 14.70K | 21.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 236.10K | 362.20K | 151.40K | 164.10K | 355.70K |
|
|
|||||
| Total Current Assets | 236.10K | 362.20K | 151.40K | 164.10K | 355.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 236.10K | 362.20K | 151.40K | 164.10K | 355.70K |
|
|
|||||
| Total Accounts Payable | 1.08M | 1.01M | 1.21M | 964.60K | 975.80K |
| Total Accrued Expenses | 377.70K | 234.40K | 214.50K | 184.40K | 187.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.67M | 723.70K | -- | -- | 1.24M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.13M | 1.97M | 1.42M | 1.15M | 2.40M |
|
|
|||||
| Total Current Liabilities | 3.13M | 1.97M | 1.42M | 1.15M | 2.40M |
| Long-Term Debt | -- | 513.80K | 1.18M | 1.23M | 1.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.13M | 2.48M | 2.60M | 2.38M | 2.40M |
|
|
|||||
| Common Stock & APIC | 6.12M | 6.10M | 5.24M | 5.44M | 5.49M |
| Retained Earnings | -9.33M | -8.48M | -7.92M | -7.88M | -7.75M |
| Treasury Stock & Other | 317.70K | 262.70K | 230.60K | 226.80K | 213.30K |
| Total Common Equity | -2.89M | -2.12M | -2.45M | -2.21M | -2.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.89M | -2.12M | -2.45M | -2.21M | -2.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.89M | -2.12M | -2.45M | -2.21M | -2.05M |
|
|
|||||